4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-19-052611
EVP, Chief Commercial Officer bought 5,143 shares at $17.50 ($90,003)
From the SEC's structured data for this filing
Trades in this filing
POYHONEN JOHN · EVP, Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-10-03 | Purchase : show line 1 in the form | +5,143 | $17.50 | $90,003 | 18,143 | D |
| Open-market purchases · 5,143 sh · avg $17.50 · $90,003 | ||||||
Loading xslF345X03/doc4.xml…